Schedule 13D ownership disclosure

Biopharmx

Security class unavailable · CUSIP: 09072X101

Event date: 2018-11-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000038777-18-000251
Form type
SC 13D/A
Filer
BioPharmX Corp
CIK
CIK 1504167
Filed
Dec 07, 2018
Reporting period
Nov 26, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub